恩捷股份(002812.SZ):海外客户包含LGES、松下、三星、法國ACC、海外某大型企業、Ultium等全球知名大型鋰電池企業
格隆匯8月15日丨恩捷股份(002812.SZ)於投資者互動平台表示,公司在海外市場和客户方面的優勢顯著,公司海外客户包含LGES、松下、三星、法國ACC、海外某大型企業、Ultium等全球知名大型鋰電池企業,而且公司還在積極開拓海外客户,同時加快推進海外產能佈局,公司的匈牙利隔膜一期項目處於客户驗證階段,美國項目按計劃實施建設,公司於2024年6月17日召開第五屆董事會第二十七次會議,同意匈牙利二期隔膜項目的建設。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.